Cone rod dystrophy (Q99750): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 16:25, 16 August 2026
Cone rod dystrophies (CRDs) are inherited retinal dystrophies that belong to the group of pigmentary retinopathies. CRDs are characterised by retinal pigment deposits, visible on fundus examination, predominantly localised to the macular region. CRD is characterised by primary cone involvement or, sometimes, by concomitant loss of both cones and rods, explaining the predominant symptoms of CRDs: decreased visual acuity, colour vision defects, photoaversion and decreased sensitivity in the central visual field, later followed by progressive loss in peripheral vision and night blindness.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_2109196114 |
||
| English | Cone rod dystrophy |
Cone rod dystrophies (CRDs) are inherited retinal dystrophies that belong to the group of pigmentary retinopathies. CRDs are characterised by retinal pigment deposits, visible on fundus examination, predominantly localised to the macular region. CRD is characterised by primary cone involvement or, sometimes, by concomitant loss of both cones and rods, explaining the predominant symptoms of CRDs: decreased visual acuity, colour vision defects, photoaversion and decreased sensitivity in the central visual field, later followed by progressive loss in peripheral vision and night blindness. |
Statements
CID11:ID_2109196114
0 references
dki-india-ID_2109196114
0 references
Concluído
0 references
15 August 2026
0 references
